Review





Similar Products

cyclophosphamide  (MedChemExpress)
94
MedChemExpress cyclophosphamide
Cyclophosphamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cyclophosphamide/product/MedChemExpress
Average 94 stars, based on 1 article reviews
cyclophosphamide - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
cyclophosphamide (cytoxan  (Baxter Healthcare)
90
Baxter Healthcare cyclophosphamide (cytoxan
Cyclophosphamide (Cytoxan, supplied by Baxter Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cyclophosphamide (cytoxan/product/Baxter Healthcare
Average 90 stars, based on 1 article reviews
cyclophosphamide (cytoxan - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
s1648 cyclophosphamide mce  (MedChemExpress)
95
MedChemExpress s1648 cyclophosphamide mce
S1648 Cyclophosphamide Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/s1648 cyclophosphamide mce/product/MedChemExpress
Average 95 stars, based on 1 article reviews
s1648 cyclophosphamide mce - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
hy 17420 dexamethasone mce  (MedChemExpress)
94
MedChemExpress hy 17420 dexamethasone mce
Hy 17420 Dexamethasone Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hy 17420 dexamethasone mce/product/MedChemExpress
Average 94 stars, based on 1 article reviews
hy 17420 dexamethasone mce - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
ctx model  (MedChemExpress)
95
MedChemExpress ctx model
Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the <t>CTX</t> group. NC: normal control, <t>CTX:</t> <t>cyclophosphamide,</t> AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Ctx Model, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctx model/product/MedChemExpress
Average 95 stars, based on 1 article reviews
ctx model - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
4 hydroperoxy cyclophosphamide  (MedChemExpress)
93
MedChemExpress 4 hydroperoxy cyclophosphamide
Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the <t>CTX</t> group. NC: normal control, <t>CTX:</t> <t>cyclophosphamide,</t> AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
4 Hydroperoxy Cyclophosphamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4 hydroperoxy cyclophosphamide/product/MedChemExpress
Average 93 stars, based on 1 article reviews
4 hydroperoxy cyclophosphamide - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
dibutyl cyclophosphamide  (MedChemExpress)
95
MedChemExpress dibutyl cyclophosphamide
Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the <t>CTX</t> group. NC: normal control, <t>CTX:</t> <t>cyclophosphamide,</t> AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Dibutyl Cyclophosphamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dibutyl cyclophosphamide/product/MedChemExpress
Average 95 stars, based on 1 article reviews
dibutyl cyclophosphamide - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the CTX group. NC: normal control, CTX: cyclophosphamide, AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Journal: Frontiers in Pharmacology

Article Title: Identify the therapeutic role and potential mechanism of α-cyperone in diminished ovarian reserve based on network pharmacology, molecular docking, Lip-MS and experimental validation

doi: 10.3389/fphar.2025.1658536

Figure Lengend Snippet: Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the CTX group. NC: normal control, CTX: cyclophosphamide, AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Article Snippet: Upon reaching approximately 80% confluency and displaying favorable condition, the cells were divided into three groups (n = 6 wells per group, three independent passages on different days): The normal control (NC group): complete medium only; CTX model (CTX group): 10 μg/mL cyclophosphamide (Sigma, C3250000) dissolved in serum-free DMEM; α-Cyperone (AC group): pre-treated with varying concentrations α-Cyperone (MedChemExpress, HY-N0710) for 6 h, followed by 10 μg/mL CTX without wash-out.

Techniques: Expressing, Gene Expression, Control